Clinical Trial on the Use of 25-OH -D Vitamin in Haemodialysis Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 284 participants.

Also called NCT01457001

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 284 participants (enrolled count) (from the registry)
Sponsor
Italian Society of Nephrology (from the registry)
Registry
  • NCT NCT01457001
Other papers using this trial's data
  • Calcifediol supplementation in adults on hemodialysis: a randomized controlled trial Journal of nephrology, 2022-03 DOI, PubMed 34173940

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01457001. Randomized; no masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2016-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial on the Use of 25-OH -D Vitamin in Haemodialysis Patients
Acronym
NUTRIVITA-D001
Condition
Chronic Renal Failure
Intervention (Drug)
25-OH-D vitamin
Lead sponsor
Italian Society of Nephrology (class: other)
Collaborator
Società Italiana di Nefrologia (class: not stated)

Record details

Record id
cardio:ct-nct01457001
Content hash
f2b5b6697519b4f99ffdad3a97c3d0d279cc5879b3ddaac96d15960927e0fc96